Kevin Caliendo
Stock Analyst at UBS
(4.26)
# 479
Out of 4,761 analysts
168
Total ratings
67.5%
Success rate
10.24%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Buy | $25 → $13 | $6.22 | +109.00% | 5 | Feb 13, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $330 → $305 | $283.81 | +7.47% | 3 | Feb 7, 2025 | |
| CI The Cigna Group | Maintains: Buy | $410 → $390 | $299.81 | +30.08% | 11 | Feb 3, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $166 → $170 | $172.24 | -1.30% | 13 | Feb 3, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $293 → $286 | $249.85 | +14.47% | 2 | Jan 28, 2025 | |
| EVH Evolent Health | Maintains: Buy | $27 → $14 | $10.43 | +34.23% | 2 | Jan 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $35 → $27 | $18.75 | +44.00% | 9 | Dec 3, 2024 | |
| CVS CVS Health | Maintains: Neutral | $60 → $62 | $63.48 | -2.33% | 6 | Nov 7, 2024 | |
| COR Cencora | Maintains: Buy | $275 → $285 | $241.43 | +18.05% | 1 | Nov 7, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $134 → $139 | $127.06 | +9.40% | 15 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $12 | $13.18 | -8.95% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $10.16 | -1.57% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $650 | $466.42 | +39.36% | 11 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $255.91 | -2.31% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $7.5 | $7.70 | -2.60% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $4.81 | +76.72% | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $72 | $77.24 | -6.78% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $12 | $11.74 | +2.21% | 2 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $620 → $630 | $597.71 | +5.40% | 13 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $190.43 | +68.04% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $26 | $20.87 | +24.58% | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $57.68 | +36.96% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $29 | $31.07 | -6.66% | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $18.61 | +39.71% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $385.10 | +49.31% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $162.30 | +10.91% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $11.51 | +525.54% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.74 | -34.29% | 4 | May 4, 2021 |
Owens & Minor
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $6.22
Upside: +109.00%
Molina Healthcare
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $283.81
Upside: +7.47%
The Cigna Group
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $299.81
Upside: +30.08%
Quest Diagnostics
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $172.24
Upside: -1.30%
Labcorp Holdings
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $249.85
Upside: +14.47%
Evolent Health
Jan 16, 2025
Maintains: Buy
Price Target: $27 → $14
Current: $10.43
Upside: +34.23%
DENTSPLY SIRONA
Dec 3, 2024
Maintains: Buy
Price Target: $35 → $27
Current: $18.75
Upside: +44.00%
CVS Health
Nov 7, 2024
Maintains: Neutral
Price Target: $60 → $62
Current: $63.48
Upside: -2.33%
Cencora
Nov 7, 2024
Maintains: Buy
Price Target: $275 → $285
Current: $241.43
Upside: +18.05%
Cardinal Health
Nov 4, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $127.06
Upside: +9.40%
Oct 30, 2024
Maintains: Neutral
Price Target: $9 → $12
Current: $13.18
Upside: -8.95%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $10.16
Upside: -1.57%
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $466.42
Upside: +39.36%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $255.91
Upside: -2.31%
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $7.70
Upside: -2.60%
Aug 9, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $4.81
Upside: +76.72%
Aug 7, 2024
Maintains: Neutral
Price Target: $75 → $72
Current: $77.24
Upside: -6.78%
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $11.74
Upside: +2.21%
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $597.71
Upside: +5.40%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $190.43
Upside: +68.04%
Jan 5, 2024
Initiates: Neutral
Price Target: $26
Current: $20.87
Upside: +24.58%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $57.68
Upside: +36.96%
Nov 30, 2023
Maintains: Neutral
Price Target: $33 → $29
Current: $31.07
Upside: -6.66%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $18.61
Upside: +39.71%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $385.10
Upside: +49.31%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $162.30
Upside: +10.91%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $11.51
Upside: +525.54%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.74
Upside: -34.29%